RVMD Revolution Medicines, Inc.: fundamentals, insider trades, fund holders

Screener

Quality checklist

0 of 2 checks passed · quarter ending 2026-06-30

ROIC at least 10%-56.4%failed
Operating margin up over 3 years—no value
Free cash flow at least 80% of net income—no value
Share count up at most 5% in 3 years96.3%failed
Net debt at most 3× EBITDA—no value
Revenue grew over 3 years—no value

Insider buying, last 90 days

No discretionary insider buying in the last 90 days.

Tracked funds, latest reports

Conviction funds

+$74.84M +0.2 pp of the company

1 buying · 0 selling · 1 holding

Active managers

+$4.2B +10.5 pp of the company

4 buying · 0 selling · 4 holding

Fundamentals

Financials

Insider trades

Fund holders

Each factor with its sector median and, where it's reported per quarter, its last 12 quarters.

Coming as the IEX price history grows (90 trading days so far): Momentum 12-1 (253), Momentum vs. sector (253), Distance from 52-week high (253), Beta (253), Max drawdown 3y (757).

Size & liquidity

RVMDSector 12 quarters Market cap $40.07B$9.9BEnterprise value $39.74B$10.41BAvg daily $ volume —$134.12MDaily turnover —1.3%Relative volume 0.5×0.9×

Growth

RVMDSector 12 quarters Revenue CAGR 3y —9.5%

Revenue CAGR 5y —9.1%

Revenue growth YoY —8.5%

Revenue acceleration —+0.1 pp

FCF growth YoY —5.2%

FCF conversion —132.6%

Forward growth (HoM est.) —9.6%

Valuation

RVMDSector 12 quarters P/E (trailing) —27.5×P/E (forward, HoM est.) —25.2×P/E vs. sector —1.0×PEG (HoM est.) —3.09EV/EBITDA —17.4×EV/Sales —3.3×FCF yield -3.1%3.6%Dividend yield 0.0%0.0%Shareholder yield 0.0%1.1%

Quality

RVMDSector 12 quarters Quality checks passed 03ROIC -56.4%8.9%

Gross profitability —32.8%

Gross margin —60.3%

Gross margin Δ 3y —+0.0 pp

Operating margin —10.1%

Operating margin Δ 3y —+1.1 pp

Debt/equity 0.2×0.7×

Net debt/EBITDA —2.0×

Interest coverage -27.4×4.5×

Share count Δ 3y 96.3%0.1%

Stock compensation / revenue —1.8%

Accruals ratio -16.2%-4.3%

Momentum & risk

RVMDSector 12 quarters Volatility 30d 50.8%29.5%

Ownership & positioning

RVMDSector 12 quarters Insider buys (90d) 00Insiders buying (90d) 00Insider net value (90d) $0$0Institutional ownership 99.8%99.3%Institutional Δ QoQ —+1.1 ppConviction funds net buying +0.2 pp+0.0 ppActive managers net buying +10.5 pp+0.1 ppActive funds net buying —+0.0 ppDays to cover —4.29Short % of shares out —6.0%Short interest Δ —+0.1 pp

Share price and valuation

$187.03 on Oct 23, 2026 · +18.4% since Jun 17, 2026

Compare with

Fund moves

Report dates

Daily close

IEX Historical Data: the last regular-session trade on IEX each day, split-adjusted, dividends not added.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Terms of use

Share price and valuation ?

Share price and valuation